These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2465967)

  • 1. Problems of the laboratory control of oral anticoagulant treatment.
    Hummel L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):529-31. PubMed ID: 2465967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of oral anticoagulant therapy.
    Biemer JJ
    Ann Clin Lab Sci; 1988; 18(6):421-8. PubMed ID: 3239946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between total prothrombin, native prothrombin and the International Normalized Ratio (INR).
    Braun PJ; Szewczyk KM
    Thromb Haemost; 1992 Aug; 68(2):160-4. PubMed ID: 1412161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
    Tripodi A; Breukink-Engbers WG; van den Besselaar AM
    Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy.
    Anderson DR; Harrison L; Hirsh J
    Arch Intern Med; 1993 Jun; 153(12):1441-7. PubMed ID: 8512435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation.
    Tripodi A; Bressi C; Carpenedo M; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Res; 2004; 113(1):35-40. PubMed ID: 15081563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of oral anticoagulant treatment in patients with venous thromboembolism.
    Pengo V
    Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Control of oral anticoagulation. Current concepts].
    Aguilar CA; Hurtado Monroy R; Gaspar Hernández J
    Rev Invest Clin; 1989; 41(4):371-4. PubMed ID: 2698502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of laboratory monitoring in oral anticoagulant therapy].
    D'Angelo G; Calvano D; Giardini C
    Minerva Med; 1993 Jun; 84(6):313-22. PubMed ID: 8336839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Normalized Ratio (INR): an improved way to monitor oral anticoagulant therapy.
    Oertel LB
    Nurse Pract; 1995 Sep; 20(9):15-6, 21-2. PubMed ID: 7501312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulant therapy control: evidence that INR expression improves the inter-laboratory comparability of results--the Bologna oral anticoagulant control exercise.
    Palareti G; Coccheri S; Poggi M; Bonetti M; Cervi V; Mazzuca A; Savoia M; Veri L; Fiori F; Gaspari G
    Thromb Haemost; 1987 Oct; 58(3):905-10. PubMed ID: 3433253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False incoagulable PT-INR results in oral anticoagulant therapy.
    Redaelli R; Corno AR; Somaini MG; Gechtman C; Caimi TM; Baudo F; Morra E
    Thromb Res; 2008; 122(1):137-9. PubMed ID: 17996923
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical liability risk avoidance: a case for adopting the International Normalized Ratio (INR) system.
    Kline SS; Atkins MO
    Am J Manag Care; 1997 Jan; 3(1):59-63. PubMed ID: 10169250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
    Horsti J
    Haematologica; 2001 Aug; 86(8):851-5. PubMed ID: 11522542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control.
    Loeliger EA; van den Besselaar AM; Lewis SM
    Thromb Haemost; 1985 Feb; 53(1):148-54. PubMed ID: 3992514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current biological surveillance of oral anticoagulant treatment].
    Helft G; Vacheron A; Samama MM
    Arch Mal Coeur Vaiss; 1995 Jan; 88(1):85-9. PubMed ID: 7646254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Present and future of oral anticoagulants].
    Meschengieser SS; Casais P; Sánchez Luceros A; Lazzari MA
    Medicina (B Aires); 2000; 60(1):139-42. PubMed ID: 10835711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
    Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
    Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.